3320 — China Resources Pharmaceutical Share News
0.000.00%
Last trade - 00:00- HK$28.93bn
- HK$167.93bn
- CNY269.57bn
Brief: China Resources Pharmaceutical Posts Qtrly Net Profit Of CR Boya Bio-Pharmaceutical RMB174.4 Million
Brief: China Resources Pharmaceutical Says Unit Recently Signed Strategic Deal
Brief: China Resources Pharmaceutical Says Recommend Final Dividend Of HK$0.16 Per Share In Cash
Brief: China Resources Pharmaceutical Group Posts FY Revenue For Jiangzhong Pharmaceutical RMB3.81 Bln
Brief: China Resources Pharmaceutical Group Ltd Says Fy Revenue For Dong-E-E-Jiao Rmb4.041 Bln
Brief: Roche, China Resources Pharma Sign Strategic Cooperation Agreement To Improve Availability Of Flu Drug Xofluza In China
Brief: China Resources Pharmaceutical Updates On FY Profit Estimates For Dong-E-E-Jiao
Brief: China Resources Pharmaceutical Says For Dong-E-E-Jiao, 9-Mth Net Profit RMB512.3 Mln
Brief: China Resources Pharmaceutical Says Total Operating Income Of Jiangzhong Pharmaceutical For 9 Mths Expected To Increase By 45%
Chinese biotech firm Brii jumps on China Resources partnership
Brief: China Resources Pharmaceutical Group Says Dong-E-E-Jiao Expects HY Net Profit Attributable Of About RMB270 -RMB340 Mln
China Resources in talks to take Sihuan Pharma private at $3 bln valuation -sources (updated)
China Resources in talks to take Sihuan Pharma private at $3 bln valuation -sources
Brief: China Resources Pharmaceutical Unit Entered Cooperation Agreement With Henan Genuine Biotech
Brief: China Resources Pharmaceutical Says On 6 May, Unit Agreed To Conditionally Purchase 28% Interest In KPC Pharmaceuticals, Inc
Brief: China Resources Pharmaceutical Says Qtrly Net Profit For Dong-E-E-Jiao RMB114.7 Mln
Brief: China Resources Pharmaceutical Group Says CR Pharmaceutical Entered Loan Agreement 2022 With CR Leasing For Loan In Principal Amount Of HK$1.2 Billion
Brief: China Resources Pharmaceutical Group Says For Q1 Jiangzhong Pharmaceutical Sees A Total Operating Income Of About RMB890 Mln
Brief: China Resources Pharmaceutical Says Unit Received Approval From China Securities Regulatory Commission For Public Issuance Of Corporate Bonds